TRGVX Performance — T. Rowe Price Global Value Equity Fund
Data updated: 2026-09-25
TRGVX returned +16.67% year to date and +35.32% over one year to Jul 2026. Annualised returns are +20.85% over 3 years and +13.07% over 5 years. The fund beat its Global Large Blend category average: $100 invested three years ago grew to $176, against $152 for the category, and to $135 over one year, against $118. Volatility over the past three years was 13.47% a year. In the 12 months to Jul 2026 the fund took in a net $80.3M, and assets reached $298.06M.
TRGVX Growth of $100
What $100 invested in T. Rowe Price Global Value Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Large Blend category average over the same months.
| Period | TRGVX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $135 | $118 |
| 3 years (Aug 2023 – Jul 2026) | $176 | $152 |
| 5 years (Aug 2021 – Jul 2026) | $185 | $148 |
| Since data start (Mar 2020 – Jul 2026) | $250 | $207 |
TRGVX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +16.67% |
| 1 year | +35.32% |
| 3 years (annualised) | +20.85% |
| 5 years (annualised) | +13.07% |
TRGVX Annual Returns
Calendar-year total returns of T. Rowe Price Global Value Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +16.67% |
| 2025 | +30.85% |
| 2024 | +13.19% |
| 2023 | +13.05% |
| 2022 | −8.07% |
| 2021 | +15.82% |
| 2020 (Mar–Dec) | +20.37% |
TRGVX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +7.8% | +5.2% | −8.9% | +8.9% | +5.2% | −0.7% | −0.7% | — | — | — | — | — |
| 2025 | +5.3% | −0.3% | −1.9% | −0.2% | +4.2% | +3.8% | +1.4% | +2.9% | +5.7% | +2.5% | +1.9% | +2.2% |
| 2024 | +0.2% | +3.8% | +5.5% | −2.2% | +3.1% | −0.5% | +2.9% | +1.9% | +0.4% | −2.3% | +5.0% | −4.8% |
| 2023 | +4.5% | −2.8% | +0.1% | +1.7% | −2.2% | +5.2% | +4.0% | −3.3% | −2.9% | −3.4% | +7.4% | +4.8% |
| 2022 | −2.4% | −1.1% | +2.1% | −6.2% | +2.4% | −7.4% | +4.2% | −3.2% | −8.2% | +7.6% | +8.2% | −2.5% |
| 2021 | −1.1% | +5.8% | +3.8% | +2.8% | +2.6% | −1.2% | −0.6% | +3.0% | −3.9% | +4.3% | −5.3% | +5.1% |
| 2020 | — | — | −19.4% | +10.0% | +4.1% | +2.3% | +4.5% | +4.2% | −3.1% | −0.8% | +15.2% | +5.6% |
TRGVX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 13.47%
- 3-year Sharpe ratio: 1.21 (vs 4.5% risk-free rate)
- Best month: +8.92% (Apr 2026)
- Worst month: −8.94% (Mar 2026)
TRGVX Fund Flows
Monthly money in and out of T. Rowe Price Global Value Equity Fund, from SEC Form N-PORT.
- 12-month net flow: $80.3M
- 12-month gross sales (incl. reinvestments): $177.3M
- Sales ÷ redemptions: 1.83×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $9.4M | $9.8M | −$422K |
| Jun 2026 | $19.0M | $17.7M | $1.2M |
| May 2026 | $16.5M | $5.6M | $11.0M |
| Apr 2026 | $9.6M | $9.2M | $365K |
| Mar 2026 | $11.5M | $8.8M | $2.7M |
| Feb 2026 | $33.9M | $25.0M | $8.9M |
| Jan 2026 | $23.1M | $5.0M | $18.1M |
| Dec 2025 | $26.9M | $3.2M | $23.7M |
| Nov 2025 | $7.4M | $4.0M | $3.5M |
| Oct 2025 | $7.8M | $3.8M | $4.0M |
| Sep 2025 | $4.9M | $2.2M | $2.6M |
| Aug 2025 | $7.4M | $2.7M | $4.7M |
TRGVX Assets Under Management
Net assets of T. Rowe Price Global Value Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $298.06M |
| 2026-04-30 | $275.80M |
| 2026-01-31 | $252.64M |
| 2025-10-31 | $195.76M |
| 2025-07-31 | $165.08M |
| 2025-04-30 | $142.26M |
| 2025-01-31 | $144.45M |
| 2024-10-31 | $144.09M |
| 2024-07-31 | $140.20M |
| 2024-04-30 | $131.58M |
| 2024-01-31 | $120.47M |
| 2023-10-31 | $104.36M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.